Real-world characteristics, treatment patterns, and overall survival in patients with metastatic breast cancer (mBC) and CNS metastases

被引：0
|
作者：
Alvarado-Miranda, A. [1 ]
Cabrera-Galeana, P. [1 ]
Munoz-Montano, W. R. [1 ]
Lara-Medina, F. [1 ]
Bargallo-Rocha, E. [1 ]
Arrieta-Rodriguez, O. [1 ]
Perez, M. [1 ]
Porras-Reyes, F. [1 ]
Mohar-Betancourt, A. [1 ]
Gamboa, C. [1 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P1-19-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-19-07
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-world treatment patterns and outcomes in ER+/PR+/HER2+metastatic breast cancer (MBC) patients: A National Cancer Database analysis.
    Statler, Abby
    Nahleh, Zeina A.
    Hobbs, Brian
    Wei, Wei
    Gupta, Annie
    Blake, Cassann N.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] The effect of age on overall survival (OS) in patients with metastatic breast cancer (MBC) treated with capecitabine
    Blum, J. L.
    Hu, X.
    Odom, D.
    Sherrill, B.
    Glueck, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Overall survival and treatment patterns among real-world patients with metastatic non-small cell lung cancer not previously treated with systemic therapy for advanced cancer
    Simeone, Jason C.
    Nordstrom, Beth
    Patel, Ketan
    Klein, Alyssa B.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [44] Overall survival and treatment patterns among real-world patients with metastatic non-small cell lung cancer not previously treated with systemic therapy for advanced cancer
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 101 - 102
  • [45] Real-world clinicopathological characteristics and treatment patterns of esophageal cancer patients in China
    Lu, Z.
    Geng, M.
    Han, Y.
    Cao, J.
    Wang, J.
    Liu, T.
    Yuan, X.
    Meng, X.
    Zhang, Y.
    Zhao, R.
    Wan, L.
    Li, E.
    Wang, W.
    Li, Z.
    Shi, D. F.
    Jing, Q.
    Shi, S.
    Dong, F.
    Shen, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1540 - S1541
  • [46] Prognostic factors are more important for overall survival (OS) than treatment outcome in patients with metastatic breast cancer (MBC).
    Schmid, P
    Wischnewsky, M
    Sezer, O
    Pape, W
    Possinger, K
    ANNALS OF ONCOLOGY, 2000, 11 : 27 - 27
  • [47] Association between bisphosphonate use in metastatic breast cancer (MBC) and overall survival
    Mathew, A.
    Rosenzweig, M. Q.
    Brufsky, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [48] Real-world survival of Danish patients with HER2-positive metastatic breast cancer
    Artzi, Daniel
    Berg, Tobias
    Celik, Alan
    Kumler, Iben
    Kenholm, Julia
    Al-Rawi, Sami
    Jensen, Maj-Britt
    Andersson, Michael
    Knoop, Ann
    ACTA ONCOLOGICA, 2023, 62 (06) : 601 - 607
  • [49] Real-world effectiveness of ribociclib in metastatic breast cancer patients: Does dose affect survival?
    Fernandez-Cuerva, Cristina
    Chinchilla-Alarcon, Teresa
    Jose Alcaraz-Sanchez, Juan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1619 - 1627
  • [50] Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR +, HER2-metastatic breast cancer patients in Japan
    Nozawa, K.
    Terada, M.
    Onishi, M.
    Ozaki, Y.
    Takano, T.
    Fakhouri, W.
    Novick, D.
    Haro, J. M.
    Faris, L. H.
    Kawaguchi, T.
    Tanizawa, Y.
    Tsurutani, Junji
    BREAST CANCER, 2023, 30 (04) : 657 - 665
12345